Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001354488-16-006317)

Filing Details

Accession Number:: 0001354488-16-006317
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-02-19 18:39:59
Reporting Period:: 2016-02-17

Filing Date:: 2016-02-19
Accepted Time:: 2016-02-19 18:39:59
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1378624	Cellular Biomedicine Group Inc.	CBMG	Biological Products, (No Disgnostic Substances) (2836)	861032927

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1569877	K Andrew Chan	19925 Stevens Creek Blvd., Suite 100 Cupertino CA 95014		No	No	No	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-02-17	1,516	$5.61	147,263	No	4	M	Direct
Common Stock	Disposition	2016-02-17	1,516	$17.76	145,747	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non- Qualified Stock Option (right to buy) (2013 Plan)	Disposition	2016-02-17	1,516	$0.00	1,516	$5.61

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
37,904		2023-05-16	No	4	M	Direct

Footnotes

The transaction reported was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 25, 2015. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
The option vested according to the following schedule: 1/31st per month following the vesting commencement date of May 16, 2014.